ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 177391 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 177391; 2) Community: the network communities that were significantly associated with the response to NSC 177391; 3) Molecule: the relationships between components within communities and NSC 177391; 4) MDR: the compounds that were significantly associated with the NSC 177391.

NSC Compound Enrichment Correlation
NSC 756377 GW814408X 0.0128195981981063 -0.0029155884
NSC 178248 Chlorozotocin 0.0130195548838506 -0.16144806
NSC 330507 Tanespimycin 0.0130195548838506 -0.22666746
NSC 408171 Null 0.0130195548838506 -0.10172768
NSC 629971 Camptothecin Derivative 0.0130195548838506 -0.27298264
NSC 641241 2-Naphthalenebutanamide, alpha-,gamma-dioxo-beta-(3-oxo -2-benzoisofuran-1-yl)-N-[3-(trifluoromethyl)phenyl]- 0.0130195548838506 0.15660215
NSC 688995 Null 0.0130195548838506 -0.1433035
NSC 176323 Camptothecin Derivative 0.0130195548838507 -0.35771188
NSC 18300 Null 0.0145418727063286 0.045254983
NSC 606699 Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt 0.0145418727063286 0.038262291
Total:19  Current:4    [First] [Prev] [Next] [Last]